Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three-dimensional visualization and analysis in prostate cancer.

Richard A Robb1

  • 1Biomedical Engineering and Biomedical Imaging, Mayo Foundation Clinic, Rochester, Minnesota 55905, USA.

Drugs of Today (Barcelona, Spain : 1998)
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging Substudy.

Circulation. Arrhythmia and electrophysiology·2021
Same author

Validation of the BRODERS classifier (Benign <i>versus</i> aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.

The European respiratory journal·2020
Same author

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

JAMA·2019
Same author

Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

PloS one·2018
Same author

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.

American heart journal·2018
Same author

Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

PloS one·2018
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Advanced medical imaging and minimally invasive techniques are revolutionizing prostate cancer diagnosis and treatment, reducing the need for surgery. Future innovations promise fully noninvasive and synchronous prostate disease management.

Area of Science:

  • Medical Imaging
  • Urology
  • Oncology

Background:

  • Prostate cancer diagnosis and treatment traditionally rely on invasive procedures and standard imaging like CT and MRI.
  • Current methods necessitate physical dissection, blind biopsies, and complex anatomical reconstruction.

Purpose of the Study:

  • To explore advancements in 3D/4D medical imaging and image-guided navigation for prostate cancer.
  • To highlight emerging minimally invasive diagnostic and therapeutic approaches for prostate disease.

Main Methods:

  • Utilizing 3D/4D imaging modalities and computer rendering for enhanced visualization.
  • Employing image-guided navigation and fusion techniques.
  • Investigating novel therapeutic modalities like microwave thermal ablation, cryosurgery, and brachytherapy.

Related Experiment Videos

Main Results:

  • New imaging approaches, including 3D ultrasound catheters, show promise for improved prostate disease diagnosis and treatment.
  • Microwave thermal ablation and cryosurgery demonstrate potential for tumor volume reduction with minimized complications.
  • Prostate brachytherapy is emerging as an effective surgical alternative.

Conclusions:

  • Combined imaging and therapeutic advancements are rapidly evolving prostate cancer care towards less invasive methods.
  • Future developments in miniaturized computing and sensing will enable fully noninvasive and synchronous diagnosis and therapy.